Medtronic Studies Cryoballoon As First-Line Atrial Fibrillation Option
This article was originally published in The Gray Sheet
Executive Summary
The firm will recruit over 200 patients across 12 European sites to evaluate if its Arctic Front Advance ablation therapy can benefit as a first-line treatment for atrial fibrillation rather than drugs.
You may also be interested in...
New Products In Brief
Debuts include Medtronic’s next-generation Arctic Front Advance for paroxysmal atrial fibrillation, Covidien’s iDrive Ultra surgical stapler and AngioDynamics’ BioFlo peripherally inserted central catheters.
AF Ablation: Surgery And Catheter Techniques Both Shine At AHA
Atrial fibrillation treatments involving standalone surgical ablation and catheter ablation were discussed in data presentations at the American Heart Association annual meeting last week.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”